Anti-PSMD13 antibody [EPR8525] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal PSMD13 antibody. Carrier free. Suitable for IHC-P, ICC/IF, WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
26S proteasome non-ATPase regulatory subunit 13, 26S proteasome regulatory subunit RPN9, 26S proteasome regulatory subunit S11, 26S proteasome regulatory subunit p40.5, PSMD13
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-PSMD13 antibody [EPR8525] - BSA and Azide free (AB248358)
This data was developed using ab131054, the same antibody clone in a different buffer formulation.Immunocytochemical analysis of HepG2 cells labelling PSMD13 with ab131054 antibody at 1/100 dilution.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PSMD13 antibody [EPR8525] - BSA and Azide free (AB248358)
This data was developed using ab131054, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin embedded Human kidney tissue labelling PSMD13 with ab131054 antibody at 1/50 dilution.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-PSMD13 antibody [EPR8525] - BSA and Azide free (AB248358)
This data was developed using ab131054, the same antibody clone in a different buffer formulation.
Actual band size : 43 kDa.
All lanes:
Western blot - Anti-PSMD13 antibody [EPR8525] (<a href='/en-us/products/primary-antibodies/psmd13-antibody-epr8525-ab131054'>ab131054</a>) at 1/1000 dilution
Lane 1:
Y79 (Human retinoblastoma cell line) cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
HepG2 cell lysate at 10 µg
Lane 4:
Jurkat cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 43 kDa
false
Reactivity data
Product details
ab248358 is the carrier-free version of ab131054.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Within the proteasome complex PSMD13 serves as a regulatory factor that assists in substrate recognition and unfolds misfolded proteins for degradation. As part of the 26S proteasome it associates with other regulatory subunits to modulate protein breakdown efficiently. This process is essential for maintaining protein homeostasis within cells allowing effective recycling of amino acids and removal of damaged or excessive proteins.
Pathways
The activity of PSMD13 is integral in the ubiquitin-proteasome pathway. This pathway is important for regulating the cellular protein quality control and turnover. PSMD13 is also involved in the NF-kB signaling pathway where it indirectly influences the activation of transcription factor NF-kB by controlling the degradation of IkB an inhibitor protein. It works with proteins like PSMD2 which cooperate in the function and efficiency of these pathways for cell regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Oncology letters 24:457 PubMed36380881
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com